BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1170137)

  • 1. Relationship of immunotherapy, seasonal pollen exposure and clinical response to serum concentrations of total IgE and ragweed-specific IgE.
    Reisman RE; Wypych JI; Arbesman CE
    Int Arch Allergy Appl Immunol; 1975; 48(6):721-30. PubMed ID: 1170137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein.
    Gleich GJ; Jacob GL
    Science; 1975 Dec; 190(4219):1106-8. PubMed ID: 1188389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximal rise in IgE antibody following ragweed pollination season.
    Henderson LL; Larson JB; Gleich GJ
    J Allergy Clin Immunol; 1975 Jan; 55(1):10-5. PubMed ID: 45925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma].
    Staikūniene J; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):244-53. PubMed ID: 12695637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.
    Lichtenstein LM; Ishizaka K; Norman PS; Sobotka AK; Hill BM
    J Clin Invest; 1973 Feb; 52(2):472-82. PubMed ID: 4119162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of IgE antibody specific for ragweed and grass allergens: binding of radiolabeled allergens by solid-phase bound IgE.
    Zeiss CR; Levitz D; Suszko IM
    J Allergy Clin Immunol; 1978 Aug; 62(2):83-90. PubMed ID: 670609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
    Kadocsa E
    Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
    Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
    Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and cellular changes accompanying the therapy of pollen allergy.
    Levy DA; Lichtenstein LM; Goldstein EO; Ishizaka K
    J Clin Invest; 1971 Feb; 50(2):360-9. PubMed ID: 4099843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
    Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF
    Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between titers of serum allergen-specific IgE and symptoms in untreated patients with seasonal allergic rhinitis.
    Nickelsen JA; Georgitis JW; Reisman RE
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):43-8. PubMed ID: 2418088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical role of specific IgE and IgG4 antibodies in patients having immunotherapy for seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Sakamoto H
    Clin Otolaryngol Allied Sci; 1998 Apr; 23(2):128-35. PubMed ID: 9597282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response.
    Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
    J Allergy Clin Immunol; 1981 Jul; 68(1):41-5. PubMed ID: 6972401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators.
    Rocklin RE; Pence H; Kaplan H; Evans R
    J Clin Invest; 1974 Mar; 53(3):735-44. PubMed ID: 4130213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal variation of IgE antibody specific for ragweed antigen E (IgE-a-AgE) from the basophil surface in patients with ragweed pollenosis.
    Grammer L; Levitz D; Roberts M; Pruzansky JJ; Zeiss CR
    Int Arch Allergy Appl Immunol; 1981; 66(2):179-88. PubMed ID: 6169651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG and IgE antibody response following Pollinex-R immunotherapy.
    Ko HS; Chen SJ; Jaworska E
    Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.